{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:43:15Z","timestamp":1776184995723,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/135(0834)\/2019-EMR-I"],"award-info":[{"award-number":["09\/135(0834)\/2019-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["6\/9-7(299)\/2022-ECD-II"],"award-info":[{"award-number":["6\/9-7(299)\/2022-ECD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016280","name":"Panjab University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijbiomac.2026.150931","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:41:08Z","timestamp":1771000868000},"page":"150931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protective efficacy of heat-killed Leishmnaia donovani vaccine adjuvanted with Toll Like Receptor 7\/8 agonist in BALB\/c mice"],"prefix":"10.1016","volume":"349","author":[{"given":"Shivani","family":"Thakur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepender","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kushvinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak B.","family":"Salunke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150931_bb0005","first-page":"123","article-title":"Evaluation of prime and prime-boost immunization strategies in BALB\/c mice inoculated with Leishmania infantum transfected with toxic plasmids","volume":"500","author":"Doe","year":"2023","journal-title":"Immunol. Methods"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0010","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.3390\/molecules27248677","article-title":"Polylactide nanoparticles as a biodegradable vaccine adjuvant: a study on safety, protective immunity and efficacy against human leishmaniasis caused by Leishmania major","volume":"27","author":"Ayari-Riabi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0015","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/vaccines7040156","article-title":"Anti-leishmanial vaccines: assumptions, approaches, and annulments","volume":"7","author":"Zutshi","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0035","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0040","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(01)00058-5","article-title":"Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG","volume":"19","author":"Misra","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0045","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0050","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"Zhang","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0055","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204491","article-title":"Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB\/c mice","volume":"13","author":"Rostamian","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0065","first-page":"1133","article-title":"TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines","volume":"56","author":"Johnston","year":"2007","journal-title":"CII"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0070","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1021\/acsptsci.4c00163","article-title":"Design and synthesis of polyphenolic imidazo [4, 5-c] quinoline derivatives to modulate toll like receptor-7 agonistic activity and adjuvanticity","volume":"7","author":"Kumar","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0075","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.biopha.2018.09.104","article-title":"Immunotherapeutic potential of Codonopsis clematidea and naringenin against visceral leishmaniasis","volume":"108","author":"Kaur","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008575","article-title":"Banerjee, in vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis","volume":"14","author":"Khanra","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.parint.2009.07.008","article-title":"Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis","volume":"58","author":"Nagill","year":"2009","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0090","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0095","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1021\/acs.jmedchem.4c00464","article-title":"Structure\u2013activity relationships toward the identification of a high-potency selective human Toll-like receptor-7 agonist","volume":"67","author":"Kaushik","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0100","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1021\/acsmedchemlett.4c00200","article-title":"Modulation of the adjuvant potential of imidazoquinoline-based TLR7\/8 agonists via alum adsorption","volume":"15","author":"Kumar","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0105","article-title":"Dual immunomodulatory and antileishmanial potential of TLR7\/8 agonists against Leishmania donovani","volume":"25","author":"Thakur","year":"2025","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-6148-10-2","article-title":"Resiquimod and polyinosinic\u2013polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine","volume":"10","author":"Zhou","year":"2014","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.591868","article-title":"The Leishmania donovani LDBPK_220120. 1 gene encodes for an atypical dual specificity lipid-like phosphatase expressed in promastigotes and amastigotes; substrate specificity, intracellular localizations, and putative role (s)","volume":"11","author":"Papadaki","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152057","article-title":"Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB\/c mice","volume":"226","author":"Goyal","year":"2021","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/microorganisms9040759","article-title":"Effects of visceralising Leishmania on the spleen, liver, and bone marrow: a pathophysiological perspective","volume":"9","author":"Poulaki","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2019.101928","article-title":"Evaluation of antileishmanial efficacy of Salidroside against the SSG-sensitive and resistant strain of Leishmania donovani","volume":"72","author":"Chauhan","year":"2019","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.micpath.2011.11.004","article-title":"Expression of infection-related genes in parasites and host during murine experimental infection with Leishmania (Leishmania) amazonensis","volume":"52","author":"Pereira","year":"2012","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0140","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/vaccines10111848","article-title":"Nanoformulations with Leishmania braziliensis antigens triggered controlled parasite burden in vaccinated golden hamster (Mesocricetus auratus) against visceral Leishmaniasis","volume":"10","author":"Ottino","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0145","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.intimp.2006.05.002","article-title":"Immunomodulatory activity of biopolymeric fraction RLJ-NE-205 from Picrorhiza kurroa","volume":"6","author":"Gupta","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0150","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.4049\/jimmunol.181.7.4613","article-title":"T cells from Leishmania major-susceptible BALB\/c mice have a defect in efficiently up-regulating CXCR3 upon activation","volume":"181","author":"Barbi","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0155","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1038\/s41598-017-03943-y","article-title":"Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis","volume":"7","author":"Roy","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0160","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.biopha.2016.08.046","article-title":"Protective inflammatory response against visceral leishmaniasis with potato tuber extract: a new approach of successful therapy","volume":"83","author":"Paik","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biologicals.2021.06.001","article-title":"Cross-protective efficacy of immuno-stimulatory recombinant Brugia malayi protein HSP60 against the Leishmania donovani in BALB\/c mice","volume":"72","author":"Kushwaha","year":"2021","journal-title":"Biologicals"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1294397","article-title":"Immunogenicity and protective efficacy of tuzin protein as a vaccine candidate in Leishmania donovani-infected BALB\/c mice","volume":"14","author":"Devender","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0175","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3389\/fimmu.2017.01943","article-title":"Immunomodulatory therapy of visceral leishmaniasis in human immunodeficiency virus-coinfected patients","volume":"8","author":"Adriaensen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0180","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","article-title":"Visceral leishmaniasis: an overview of vaccine adjuvants and their applications","volume":"37","author":"Ratnapriya","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0185","article-title":"Conjugation of TLR7 and TLR7\/8 agonists onto weak protein antigen via versatile oxime ligation for enhanced vaccine efficacy","volume":"278","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2023.01.062","article-title":"Novel sialoglycan linkage for constructing adjuvant\u2013protein conjugate as potent vaccine for COVID-19","volume":"355","author":"Wen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0195","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/IAI.68.4.1840-1848.2000","article-title":"Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani","volume":"68","author":"Cotterell","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0200","doi-asserted-by":"crossref","first-page":"12962","DOI":"10.1038\/s41598-019-49344-1","article-title":"Pro-cellular exhaustion markers are associated with splenic microarchitecture disorganization and parasite load in dogs with visceral leishmaniasis","volume":"9","author":"de Souza","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.895234","article-title":"Leishmania tarentolae as potential live vaccine co-expressing distinct salivary gland proteins against experimental cutaneous leishmaniasis in BALB\/c mice model","volume":"13","author":"Lajevardi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0210","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-014-0653-6","article-title":"Role of CD8+ T cells in protection against Leishmania donovani infection in healed visceral Leishmaniasis individuals","volume":"14","author":"Kaushal","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0225","article-title":"Reactive oxygen species and nitric oxide in cutaneous leishmaniasis","volume":"2012","author":"Horta","year":"2012","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/srep10706","article-title":"Genetically engineered ascorbic acid-deficient live mutants of Leishmania donovani induce long lasting protective immunity against visceral leishmaniasis","volume":"5","author":"Anand","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0235","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jac\/dkq164","article-title":"CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis","volume":"65","author":"Sane","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10238-001-8025-0","article-title":"Nitric oxide production by Leishmania-infected macrophages and modulation by prostaglandin E 2","volume":"1","author":"Panaro","year":"2001","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.vetpar.2013.09.011","article-title":"Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis","volume":"198","author":"Resende","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112538","article-title":"PLGA nanoparticle-delivered Leishmania antigen and TLR agonists as a therapeutic vaccine against cutaneous leishmaniasis in BALB\/c mice","volume":"138","author":"Katebi","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0255","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/microorganisms8081201","article-title":"Leishmania immunity: advancing immunotherapy and vaccine development","volume":"8","author":"Ikeogu","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bjid.2014.10.009","article-title":"Therapy with radio-attenuated vaccine in experimental murine visceral leishmaniasis showed enhanced T cell and inducible nitric oxide synthase levels, suppressed tumor growth factor-beta production with higher expression of some signaling molecules","volume":"19","author":"Datta","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0265","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00436-015-4347-9","article-title":"Inducible nitric oxide synthase response and associated cytokine gene expression in the spleen of mice infected with Clonorchis sinensis","volume":"114","author":"Shen","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0270","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.vaccine.2022.05.063","article-title":"Evaluation of prime and prime-boost immunization strategies in BALB\/c mice inoculated with Leishmania infantum transfected with toxic plasmids","volume":"40","author":"Roque","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0275","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/eji.201242428","article-title":"TLR-mediated distinct IFN-\u03b3\/IL-10 pattern induces protective immunity against murine visceral leishmaniasis","volume":"42","author":"Paul","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0280","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/ph16050707","article-title":"High selectivity of 8-Hydroxyquinoline on Leishmania (Leishmania) and Leishmania (Viannia) species correlates with a potent therapeutic activity in vivo","volume":"16","author":"Lima","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fimmu.2016.00153","article-title":"The contribution of immune evasive mechanisms to parasite persistence in visceral leishmaniasis","volume":"7","author":"De Freitas","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000484","article-title":"Vector transmission of Leishmania abrogates vaccine-induced protective immunity","volume":"5","author":"Peters","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0295","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/505584","article-title":"Synthetic glycovaccine protects against the bite of Leishmania-infected sand flies","volume":"194","author":"Rogers","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150931_bb0300","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.vaccine.2018.04.082","article-title":"Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus","volume":"36","author":"Jung","year":"2018","journal-title":"Vaccine"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026008573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026008573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:43:58Z","timestamp":1776181438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026008573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":60,"alternative-id":["S0141813026008573"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150931","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective efficacy of heat-killed Leishmnaia donovani vaccine adjuvanted with Toll Like Receptor 7\/8 agonist in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150931"}}